Biotech media outlet Labiotech.eu which covers the European Biotech industry, has today, 21 May…

Elasmogen’s CEO Dr Caroline Barelle has been featured in Insight Success special…

Funding from Deepbridge Capital, Innovate UK and Scottish Investment Bank will support development…

Combined Feldan Shuttle and Elasmogen soloMER technology will be used to deliver intracellular…

Elasmogen’s CEO, Caroline Barelle is featured in Converge’s podcast where she discusses her…

Elasmogen’s CEO Dr Caroline Barelle has been named in Labiotech.eu’s list of top female…

We are delighted that The Times has featured Elasmogen in an article titled ‘Ruthless killers?…

Dr. Caroline Barelle (CEO) has been selected as a finalist for the Rising Stars: Extraordinary…

Funding from Deepbridge Capital will support development of next generation biologics January 10th…

17th May 2018: Aberdeen, Scotland: Elasmogen Ltd, developer of soloMERTM biologics, today…

Elasmogen has been nominated for a Life Science Award with Almac Discovery in the Innovative…

£2M joint program receives grant to support research into next generation technology Craigavon,…